Battelle Memorial Institute
Battelle Memorial Institute is a large, nonprofit research and development organization headquartered in Columbus, Ohio, that provides a wide range of scientific, engineering, technical, and manufacturing services to federal government agencies. As a premier independent research organization, Battelle operates with a mission to translate scientific discovery and technology innovation into societal impact across multiple domains including defense, homeland security, health, energy, and environmental sectors. The organization leverages its extensive technical capabilities to deliver complex research, testing, development, and manufacturing solutions through federal contract and grant awards, serving as both a prime and subcontractor for numerous U.S. government agencies.
Through federal contract awards, Battelle Memorial Institute has demonstrated remarkable versatility in delivering goods and services across diverse domains. The organization provides critical research and development services in areas such as chemical and biological defense, environmental remediation, vehicle procurement, technology testing, and engineering support. Significant contract work includes developing advanced military vehicles for the U.S. Special Operations Command, conducting environmental testing and monitoring for the U.S. Army Corps of Engineers, performing research for defense agencies like DARPA, and supporting homeland security initiatives through the Department of Homeland Security Science and Technology Directorate. Battelle frequently works with specialized subcontractors and has received numerous contract awards without specific small business set-aside designations, indicating its ability to compete effectively in full and open competition.
Battelle's federal grant awards reflect its commitment to advancing scientific knowledge and addressing complex national challenges. The organization has received grants from agencies like the National Science Foundation, Department of Energy, and National Telecommunications and Information Administration to support innovative research initiatives. Notable grant projects include developing an interoperable open radio access network (open RAN) technology, conducting carbon capture and storage feasibility studies, supporting ecological research through the National Ecological Observatory Network, and advancing medical research in areas like infectious disease modeling and critical materials recycling. Battelle often collaborates with universities and research institutions as a prime grantee, leveraging its scientific expertise to pursue cutting-edge research that addresses significant societal and technological challenges.
Battelle Memorial Institute holds several significant federal contract Indefinite Delivery/Indefinite Quantity (IDIQ) contracts that provide flexible access to its extensive capabilities. These include the One Acquisition Solution for Integrated Services Plus (OASIS+) Unrestricted contract with a massive $999,999,999,999 ceiling value, a $120 million Human Factors IDIQ with the National Highway Traffic Safety Administration, and a $350 million non-standard commercial vehicles IDIQ with U.S. Special Operations Command. The organization also holds specialized other transaction agreements like the DARPA EQUIP-A-PHARMA contract and a $146.3 million single-award IDIQ with the National Institute of Allergy and Infectious Diseases for pre-clinical infectious disease models. These contract vehicles demonstrate Battelle's ability to provide comprehensive, flexible scientific and technical services across multiple federal agencies and research domains.
F125YU6SWK59 541715
Not listed 505 King Ave, Columbus, OH 43201, USA
12/6/01 6/16/26 Lovelace Biomedical And Environmental Research Institute, Inc.
Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), doing business as Inhalation Toxicology Research Institute, is a not-for-profit contract research organization that provides preclinical research services to support the development of treatments and cures for respiratory diseases. As a subsidiary of Lovelace Biomedical Research Institute, LBERI leverages over 70 years of expertise in inhalation toxicology, infectious disease modeling, medical countermeasure testing, and translational science.
Through prime and subcontract awards, LBERI performs preclinical efficacy testing of HIV therapeutics, models pharmacodynamics of gene targets related to pain disorders, evaluates medical countermeasures for COVID-19, provides infectious disease modeling services, and conducts research on opioid addiction and withdrawal treatments. Major federal customers include NIH, NIAID, NCATS, BARDA, and Leidos. LBERI has provided these R&D services via cost-plus-fixed-fee and firm-fixed-price delivery orders issued under IDIQ contracts, with no set aside designations.
LBERI also conducts biomedical research on a range of disease states through NIH research project grants. As a prime grantee, LBERI performs studies on neural circuitry and dopamine reward response related to substance abuse. As a subrecipient on NIH awards to universities, LBERI contributes expertise in lung disease modeling, translational science, and biodistribution assays to support research on lung cancer, chronic bronchitis, and nanoparticle inhalation exposure.
N1UBCLRAPNG6 541380
Not listed Not listed 2/28/02 3/14/24 University Of Illinois
The University of Illinois, doing business as The Board of Trustees of the University of Illinois, is a major public research university with a comprehensive mission of education, research, and public service. As a federal contractor and grantee, the university provides a wide range of research, development, and technical services across multiple scientific, medical, and technological domains. With campuses in Chicago and Urbana-Champaign, the university is a prominent institution of higher education that engages extensively with federal agencies to advance scientific knowledge, develop innovative technologies, and address critical national challenges.
Through its federal contract awards, the University of Illinois has performed diverse technical and scientific services for various government agencies. These contracts have included veterinary services for the Department of Veterans Affairs, research on welding technologies for NASA, environmental and engineering studies for the Naval Facilities Engineering and Expeditionary Warfare Center, and technical consulting for the U.S. Army Corps of Engineers. The university's contracts are predominantly not set aside for specific business types, indicating its broad capability to compete for federal work across multiple domains. Notable contract partners have included agencies like the Shared Services Center and various Department of Defense components.
The university's federal grant awards demonstrate extensive research capabilities across numerous scientific and medical disciplines. These grants span areas such as healthcare, biomedical research, mathematics, artificial intelligence, environmental science, and technology development. Major funding agencies include the National Institutes of Health, National Science Foundation, Department of Energy, and Department of Defense. Grant projects have addressed critical research questions like developing AI technologies, investigating neurological disorders, exploring climate health equity, studying cancer mechanisms, and advancing mathematical theories. The grants often involve collaborative efforts with other research institutions and aim to generate new scientific knowledge and technological innovations.
The University of Illinois holds an Indefinite Delivery Contract with the National Heart Lung and Blood Institute for the Hispanic Community Health Study - Study of Latinos (HCHS-SOL) Chicago Field Center. This contract, valued at $21,000,000 with an ultimate completion date of November 29, 2033, represents a significant long-term federal research engagement. The initial $13,833,140 delivery order supports core study operations for the HCHS-SOL, focusing on epidemiological research to understand health outcomes in Hispanic/Latino populations. This contract exemplifies the university's capacity to manage complex, multi-year federal research initiatives across substantial funding levels and with specific programmatic objectives.
W8XEAJDKMXH3 611310
Not listed 809 S Marshfield Ave, Chicago, IL 60612, USA
5/14/02 12/19/25 Snbl U.s.a., LTD.
--
KVT6LM4NS5N4 541714
Not listed Not listed 2/23/09 3/23/19 University Of Maryland, Baltimore
The University of Maryland, Baltimore (UMB) is a prominent public research university and academic health center located in Baltimore, Maryland. As a major academic institution, UMB provides a wide range of goods and services to the federal government through complex research contracts and grants across multiple disciplines, including medicine, nursing, pharmacy, dentistry, law, and social work. The university serves as a prime contractor and sub-recipient for numerous federal agencies, leveraging its extensive expertise in biomedical research, clinical trials, healthcare services, and professional education. UMB is recognized for its innovative research capabilities, particularly in areas such as infectious diseases, cancer research, neurological disorders, and public health interventions.
Through its federal contract awards, UMB has delivered diverse services including veterinary care services for VA research teams, laboratory services, medical research support, and specialized clinical consultation. The university has received contracts from agencies like the Department of Veterans Affairs, Department of Defense, National Institutes of Health, and Department of the Navy. These contracts span various domains such as reagent and supply provision, instrumentation services, laboratory testing, and professional consulting. Most of UMB's federal contract awards have been issued without specific set-aside designations, indicating the university's broad competitive capabilities across multiple research and service domains.
UMB's federal grant awards cover an extensive range of research and academic initiatives, with a strong focus on advancing medical and scientific knowledge. The university has received grants from agencies including the National Institutes of Health, National Institute of Mental Health, National Cancer Institute, and Department of Defense to support research in areas such as infectious diseases, cancer treatment, neurological disorders, substance abuse, and public health interventions. These grants support critical research projects ranging from developing novel therapeutics and understanding disease mechanisms to creating training programs for future researchers and addressing health disparities.
UMB holds two significant federal contract Indefinite Delivery Vehicles (IDVs): a $6 million Blanket Purchase Agreement with the Department of Veterans Affairs for reagents, supplies, laboratory services, instrumentation, and veterinary care services, and a $245,000 agreement with the Uniformed Services University of the Health Sciences for providing cadavers for medical training and research. These IDVs demonstrate the university's capacity to provide specialized scientific and educational resources across multiple federal agencies. The agreements allow for flexible, ongoing procurement of critical research and educational materials, highlighting UMB's role as a key partner in advancing federal research and medical training objectives.
Z9CRZKD42ZT1 611310
Not listed 220 N Arch St, Baltimore, MD 21201, USA
3/18/02 1/2/26